The present results are consistent with the results from previous studies, and support the hypothesis that the 40-kDa membrane-bound form of mesothelin is the active form, which promotes aggressive cellular characteristics, including an increase in cell motility, invasive or migratory ability, and growth of metastatic tumors (15–17). Here, MSLN is linked to metastatic neoplasm.